Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.

Sutharsan S, Fischer R, Gleiber W, Horsley A, Crosby J, Guo S, Xia S, Yu R, Newman KB, Elborn JS

DOI: 10.1183/23120541.00986-2023
Published: 2024 Jul
Container: ERJ open research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00986-2023,
  title = {Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.},
  author = {Sutharsan S and Fischer R and Gleiber W and Horsley A and Crosby J and Guo S and Xia S and Yu R and Newman KB and Elborn JS},
  year = {2024},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00986-2023},
  url = {https://doi.org/10.1183/23120541.00986-2023}
}

RIS

TY  - JOUR
TI  - Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.
AU  - Sutharsan S
AU  - Fischer R
AU  - Gleiber W
AU  - Horsley A
AU  - Crosby J
AU  - Guo S
AU  - Xia S
AU  - Yu R
AU  - Newman KB
AU  - Elborn JS
PY  - 2024
JO  - ERJ open research
DO  - 10.1183/23120541.00986-2023
UR  - https://doi.org/10.1183/23120541.00986-2023
ER  -

APA

S, S., R, F., W, G., A, H., J, C., S, G., S, X., R, Y., KB, N., & JS, E. (2024). Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.. ERJ open research. https://doi.org/10.1183/23120541.00986-2023

Source records

pubmed · retrieved 2026-09-25T15:04:21.755Z